Regenerative Medical Technology Group Inc.
RMTG
$0.0254
-$0.0212-45.49%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.24% | -149.30% | 84.85% | -2.29% | -17.41% |
| Total Depreciation and Amortization | -32.38% | -128.69% | -10.03% | 43.35% | 35.34% |
| Total Amortization of Deferred Charges | -- | -99.42% | -91.36% | 34.81% | 33.79% |
| Total Other Non-Cash Items | -20.00% | 99.94% | -99.97% | 170.00% | 134.09% |
| Change in Net Operating Assets | -20.90% | 18.76% | 14.16% | 31.24% | 12.49% |
| Cash from Operations | -47.13% | 1,390.48% | 2,601.98% | 122.23% | 1,488.24% |
| Capital Expenditure | -- | 82.39% | 41.36% | -1,021.28% | -976.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 82.39% | 41.36% | -1,021.28% | -976.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.01% | 153.70% | 370.07% | 109.16% | 667.44% |